Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CABA
CABA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CABA News
Cabaletta Bio Reports Q1 Earnings Beat
May 14 2026
seekingalpha
Cabaletta Bio's Therapy Shows Promising Results in Pemphigus Vulgaris
May 04 2026
stocktwits
Cabaletta Bio Raises $150M Through Share Offering
May 04 2026
seekingalpha
Cabaletta Bio to Present New Therapy Data at ASGCT Meeting
Apr 27 2026
Yahoo Finance
Cellares Successfully Infuses CAR T Therapy into Cabaletta Bio Patients
Apr 15 2026
seekingalpha
Cellares and Cabaletta Bio Successfully Infuse First Patients with Rese-cel
Apr 14 2026
Newsfilter
Cabaletta Bio Reports Q4 Earnings Beat with Cash Position Update
Mar 23 2026
seekingalpha
Cabaletta Bio (CABA) Shares Surge 11% Following Insider Purchases
Jan 22 2026
seekingalpha
High Roller Technologies Inc Closes Direct Offering, Raises $25 Million
Jan 22 2026
Benzinga
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%
Jan 22 2026
NASDAQ.COM
Cabaletta Bio (CABA) Shares Rise Nearly 6% on Clinical Progress
Jan 20 2026
NASDAQ.COM
FDA's Strict Stance Creates Uncertainty for uniQure's Fast-Tracked Huntington's Gene Therapy
Nov 04 2025
Benzinga
Top Analysts Recommend 3 Best Stocks to Purchase Now, 10/10/2025
Oct 10 2025
TipRanks
HC Wainwright & Co. Affirms Buy Rating for Cabaletta Bio, Keeps $16 Price Target Intact
Oct 10 2025
Benzinga
Cabaletta Bio Unveils Initial Rese-cel Data Without Preconditioning, Showcasing Biological Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
Oct 09 2025
Newsfilter
PRFZ's Holdings May Offer 13% Profit Potential
Sep 23 2025
NASDAQ.COM
Show More News
